Jilin Province Huinan Changlong Bio-pharmacy Co Ltd ($8049) - buy or sell? Stock discussion, ideas, forum

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes biochemical medicines in China under the brand names of Changlong and Shendi.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$8049	HKEx GEM	CNE100000130	Code: 8049

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8049 stock

Share your investment idea or question on Jilin Province Huinan Changlong Bio-pharmacy Co Ltd stock:

Latest twits on Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049)

No twits yet. Be the first to post!

Have a question about 8049? Ask and other investors will be eager to help you.

Have an idea about 8049? Share it with other investors.

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd news

30/03/2016 Jilin Province Huinan Changlong Bio-pharmacy Co Ltd EBITDA dropped on 25.3% in 2015 and EBITDA Margin decreased on 5.6 pp from 33.6% to 28.0%

06/04/2015 Eye on Jilin Province Huinan Changlong Bio-pharmacy Co Ltd as a growth stock

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd stock price chart

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	200.6	274.3	353.2
EBITDA	58.994	73.297	75.936
Net income	35.891	50.893	58.754
CAPEX	4.166	37.719	87.853
Debt	6.690	7.070	11.450
Cash	97.559	70.059	89.374

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd news

About Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes biochemical medicines in China under the brand names of Changlong and Shendi. The Company also manufactures and distributes Chinese medicines and Western medicines.